BCC vs BMY · P/E 23, rev $3.33B vs P/E 17, rev $24.46B
Boise Cascad Llc (BCC) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Boise Cascad Llc (BCC) is a lumber & wood production company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported BCC revenue for 2026-06-30 was $3.33B. Net income was $75.2M. BCC currently screens at market cap $2.40B and trailing P/E 22.9.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BCC currently screens at market cap $2.40B and trailing P/E 22.9. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the BCC and BMY stock pages for the full models.
Not investment advice.